Terms: = Breast cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Treatment
339 results:
1. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer.
Li JJ; Yu T; Zeng P; Tian J; Liu P; Qiao S; Wen S; Hu Y; Liu Q; Lu W; Zhang H; Huang P
Nat Commun; 2024 Apr; 15(1):3445. PubMed ID: 38658533
[TBL] [Abstract] [Full Text] [Related]
2. [Metformin suppresses hypoxia-inducible factor-1
Shao S; Bai W; Zhou P; Luo M; Zhao X; Lei J
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):428-436. PubMed ID: 38597433
[TBL] [Abstract] [Full Text] [Related]
3. Novel furan chalcone modulates PHD-2 induction to impart antineoplastic effect in mammary gland carcinoma.
Rastogi S; Ansari MN; Saeedan AS; Singh SK; Mukerjee A; Kaithwas G
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23679. PubMed ID: 38486411
[TBL] [Abstract] [Full Text] [Related]
4. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
5. Research progress on the role of reactive oxygen species in the initiation, development and treatment of breast cancer.
Zhong J; Tang Y
Prog Biophys Mol Biol; 2024 May; 188():1-18. PubMed ID: 38387519
[TBL] [Abstract] [Full Text] [Related]
6. Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review.
Liu L; Bai J; Hu L; Jiang D
Medicine (Baltimore); 2023 Oct; 102(43):e35493. PubMed ID: 37904441
[TBL] [Abstract] [Full Text] [Related]
7. Echinacoside regulates PI3K/AKT/HIF-1α/VEGF cross signaling axis in proliferation and apoptosis of breast cancer.
Liang H; Yin G; Shi G; Liu Z; Liu X; Li J
Anal Biochem; 2024 Jan; 684():115360. PubMed ID: 37865269
[TBL] [Abstract] [Full Text] [Related]
8. Iridium nanozyme-mediated photoacoustic imaging-guided NIR-II photothermal therapy and tumor microenvironment regulation for targeted eradication of cancer stem cells.
Yao Y; Zhao Z; He J; Ali B; Wang M; Liao F; Zhuang J; Zheng Y; Guo W; Zhang DY
Acta Biomater; 2023 Dec; 172():369-381. PubMed ID: 37852456
[TBL] [Abstract] [Full Text] [Related]
9. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].
Tan XY; Tao J; Zhang Y; Gu RX
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5056-5067. PubMed ID: 37802848
[TBL] [Abstract] [Full Text] [Related]
10. New insights into the cytotoxic effects of Thymus vulgaris essential oil on the human triple-negative breast cancer cell line MDA-MB-231.
Benedetti S; Nasoni MG; Luchetti F; Palma F
Toxicol In Vitro; 2023 Dec; 93():105705. PubMed ID: 37775061
[TBL] [Abstract] [Full Text] [Related]
11. CHSY1 promotes CD8
Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
[TBL] [Abstract] [Full Text] [Related]
12. CPNE1 mediates glycolysis and metastasis of breast cancer through activation of PI3K/AKT/HIF-1α signaling.
Cao J; Cao R; Liu Y; Dai T
Pathol Res Pract; 2023 Aug; 248():154634. PubMed ID: 37454492
[TBL] [Abstract] [Full Text] [Related]
13. A PDA-Functionalized 3D Lung Scaffold Bioplatform to Construct Complicated breast Tumor Microenvironment for Anticancer Drug Screening and Immunotherapy.
Zhang W; Chen Y; Li M; Cao S; Wang N; Zhang Y; Wang Y
Adv Sci (Weinh); 2023 Sep; 10(26):e2302855. PubMed ID: 37424037
[TBL] [Abstract] [Full Text] [Related]
14. Ponatinib delays the growth of solid tumours by remodelling immunosuppressive tumour microenvironment through the inhibition of induced PD-L1 expression.
Barnwal A; Tamang R; Sanjeev Das ; Bhattacharyya J
Br J Cancer; 2023 Oct; 129(6):1007-1021. PubMed ID: 37400678
[TBL] [Abstract] [Full Text] [Related]
15. Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration.
Cui L; Ye C; Luo T; Jiang H; Lai B; Wang H; Chen Z; Li Y
J Vis Exp; 2023 Jun; (196):. PubMed ID: 37358272
[TBL] [Abstract] [Full Text] [Related]
16. Construction of carboxymethyl chitosan-based nanoparticles of hypoxia response for co-loading doxorubicin and tanshinone IIA.
Lu M; Ma L; Li J; Li J; Tong M; Dai F; Song F; Zhang X; Qiu T
Int J Biol Macromol; 2023 Jul; 244():125362. PubMed ID: 37330079
[TBL] [Abstract] [Full Text] [Related]
17. Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells.
Das B; Dash SR; Patel H; Sinha S; Bhal S; Paul S; Das C; Pradhan R; Ahmed I; Goutam K; Kundu CN
Phytomedicine; 2023 Aug; 117():154914. PubMed ID: 37321076
[TBL] [Abstract] [Full Text] [Related]
18. PET/MRI of hypoxia and vascular function in ER-positive breast cancer: correlations with immunohistochemistry.
Carmona-Bozo JC; Manavaki R; Miller JL; Brodie C; Caracò C; Woitek R; Baxter GC; Graves MJ; Fryer TD; Provenzano E; Gilbert FJ
Eur Radiol; 2023 Sep; 33(9):6168-6178. PubMed ID: 37166494
[TBL] [Abstract] [Full Text] [Related]
19. ZnO Nanorods Create a Hypoxic State with Induction of HIF-1 and EPAS1, Autophagy, and Mitophagy in cancer and Non-cancer Cells.
Aventaggiato M; Preziosi A; Cheraghi Bidsorkhi H; Schifano E; Vespa S; Mardente S; Zicari A; Uccelletti D; Mancini P; Lotti LV; Sarto MS; Tafani M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108134
[TBL] [Abstract] [Full Text] [Related]
20. Synergistic actions of Alpelisib and Melatonin in breast cancer cell lines with PIK3CA gene mutation.
de Godoy BLV; Moschetta-Pinheiro MG; Chuffa LGA; Pondé NF; Reiter RJ; Colombo J; Zuccari DAPC
Life Sci; 2023 Jul; 324():121708. PubMed ID: 37086897
[TBL] [Abstract] [Full Text] [Related]
[Next]
